Navigation Links
Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program - 3 p.m., Tuesday, October 27
Date:10/13/2009

CAMBRIDGE, Mass., Oct. 13 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide details on Cequent's planned launch of its clinical program and highlight strategy and development goals in a company update scheduled for 3 p.m. on Tuesday, October 27, 2009, at the 2009 BIOCOM Investor Conference. The company has initiated a Series B round of financing; it is seeking to raise $15 million to take the company through Phase II clinical trials with its lead drug candidate.

Cequent is using the company's proprietary TransKingdom RNA interference (tkRNAi) technology to develop RNAi-based therapeutics - a new class of drugs designed to work by effectively deactivating the specific gene or genes implicated in the progression of a disease. The company has made considerable progress with its programs targeting polyposis and inflammatory bowel disease (IBD), demonstrating through in vivo testing and studies with non-human primates that its tkRNAi technology can silence target genes successfully. It expects to file its first IND (investigational new drug) application with the U.S. Food and Drug Administration for an orally administered tkRNAi drug targeting the primary oncogene in FAP (familial adenomatous polyposis) before the end of the quarter. FAP is a rare inherited gastrointestinal disease that causes hundreds to thousands of precancerous polyps to form in the colon, leading to colon cancer.

Cequent completed a $15 million Series A financing in June of 2007. Investors included Ampersand Ventures, Pappas Ventures, Yasuda, and the Novartis Option Fund.

2009 BIOCOM Investor Conference

The fourth annual BIOCOM Investor Conference takes place October 26 - 27, 2009, at the Hyatt Regency La Jolla, California. For more informat
'/>"/>

SOURCE Cequent Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
2. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
3. Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.
4. Cequent Names Ted Hibben Chief Business Officer
5. Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases
6. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
7. CardioDynamics Provides 2007 Shareholder Meeting Update
8. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
9. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
10. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
11. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...able in German . , Whether it,s CD packagin...Radio Frequency Identification) are increasingly f...possible to label objects or goods and identify th...te scanner can read and process the data contained...s under production conditions of up to 100 degrees...
(Date:11/24/2009)...,Nov.24/PRNewswire/--Twomoreprestigiousuniversitie...ejobboardandcareerssiteforlifescienceprofessionals...bersofthejobboard,joining28othermajorlifesciencetr...ercenter.com ,isonlyforpost-graduatesinthelifescie...ontheInternet,BioCareerCenteristheonlyonethatserve...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
(Date:11/24/2009)...PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chin...edthe,investigationalnewdrugapplication(IND)forits...mulationtotreatdiabetes.ThisIND,approvalallowsBiol...iabetesisadisordercharacteristicofhighbloodglucose...resultinseveremicro-and,macro-vasculardiseases,los...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...stry publication R&D Directions honors Dr. Sel...dies , , CINCINNATI, March 26 Kendle (Nasdaq: ...search organization, today announced Edward Seller...f the company,s Early Stage Unit in Toronto, has b...by leading industry publication R&D Direction...
...DIEGO, March 26 David Koos, Chairman and CEO of S...OTC Bulletin Board: BMSN) announced today that the...25 by researchers at the National Institutes of He...for Leukemia treatment and artificially culturing ...ll "storage" facilities that meet rigid state and ...
... , SAN JOSE, Calif., March 26 NeuroSky, Inc., a b...nnounces today the launching of the MindSet(TM), a...ional technology for a wireless Bluetooth(R) heads...products. With two earlier toy companies announcin...TM) and the Uncle Milton Force Trainer(TM) (und...
Other Biology Technology:Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D' 2Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D' 3NIH News Confirms Trend in Stem Cell 'Storage' Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group 2NeuroSky to Launch Brainwave-Based Technology for Stereo Headsets for Personal Computers 2NeuroSky to Launch Brainwave-Based Technology for Stereo Headsets for Personal Computers 3
(Date:11/25/2009)...eat may be just as vital to your health as what yo... Biological Studies. Their experiments in mice rev...s of genes in the liverthe body,s metabolic cleari... by the body,s circadian clock as conventional wis...ctivity of a large number of genes completely inde...
(Date:11/24/2009)...ng new doors to understanding how sounds associate...rine mammal or if they hear it at all. , The sa...hat NASA uses to detect flaws in the space shuttle...entists to peek inside the giant head of a whale. ... replicas of a whale,s hearing anatomy using a bre...
(Date:11/24/2009)... of a remarkable class of ring-shaped protein moto...ence Berkeley National Laboratory (Berkeley Lab) u...amline at the Advanced Light Source (ALS). These p...n and replication, and are vital to the survival o...ts, such as the human papillomavirus, which has be...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Prometheus Launches ProOnc Dx Cancer Diagnostics 5507 1Prometheus Launches ProOnc Dx Cancer Diagnostics 5507 2Prometheus Launches ProOnc Dx Cancer Diagnostics 5507 3Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax 28R 29 Sprinkle Capsules 5505 1Aethlon Medical Announces Presentation of Hepatitis C 28HCV 29 Clinical Data at 42nd Annual American Society of Nephrology 28ASN 29 Conference 5503 1Aethlon Medical Announces Presentation of Hepatitis C 28HCV 29 Clinical Data at 42nd Annual American Society of Nephrology 28ASN 29 Conference 5503 2Aethlon Medical Announces Presentation of Hepatitis C 28HCV 29 Clinical Data at 42nd Annual American Society of Nephrology 28ASN 29 Conference 5503 3
...ovember 13, 2008) In a report now available onlin...ber 2008 issue of the Journal of Urology, Univer...Herr, PhD and his colleagues have confirmed the ac...e first FDA approved at-home immunodiagnostic test...rr, a professor of Cell Biology and director of UV...
...8) -- Not knowing which way is up can have deadly ...ses, called spatial disorientation, is responsible...s in the United States, with 90 percent of these b...nistration. , Although there have been no spatia... concern for astronaut pilots. A National Space Bi...
...s" are so sensitive that they can feel the tell-ta...d samples, yet don,t ever need to be sterilizedor ... National Institute of Standards and Technology (N...chnique for detecting and measuring very small con...us on a surface. NIST has issued a non-exclusive l...
Other Biology News:First at-home test for vasectomized men proves to be safe, accurate 2Space researchers developing tool to help disoriented pilots 2Space researchers developing tool to help disoriented pilots 3
Human Granulocyte Macrophage Colony Stimulating Factor, Unconjugated from PeproTech
...udes: Sufficient library for 10 separate biopannin...quences, -28 gIII Sequencing Primer (100 pmol), fo...r (100 pmol), for automated DNA sequencing, Host E...) and Elutant (Biotin), Detailed protocols for sur...
ReBlot Western Blot Recycling Kit - Trial from CHEMICON
ELISA Strips from Santa Cruz Biotechnology, Inc.
Biology Products: